Amundi’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.5M | Sell |
909,429
-425,861
| -32% | -$12.9M | 0.01% | 655 |
|
|
2025
Q1 | $34.4M | Buy |
1,335,290
+129,017
| +11% | +$3.32M | 0.01% | 606 |
|
|
2024
Q4 | $52.1M | Buy |
1,206,273
+535,273
| +80% | +$23.1M | 0.02% | 550 |
|
|
2024
Q3 | $39.2M | Sell |
671,000
-64,429
| -9% | -$3.76M | 0.01% | 592 |
|
|
2024
Q2 | $85.3M | Buy |
735,429
+87,840
| +14% | +$10.2M | 0.03% | 411 |
|
|
2024
Q1 | $66.1M | Sell |
647,589
-106,771
| -14% | -$10.9M | 0.03% | 467 |
|
|
2023
Q4 | $83.1M | Buy |
754,360
+187,810
| +33% | +$20.7M | 0.04% | 426 |
|
|
2023
Q3 | $55.7M | Buy |
566,550
+1,788
| +0.3% | +$176K | 0.03% | 488 |
|
|
2023
Q2 | $68.7M | Sell |
564,762
-148,048
| -21% | -$18M | 0.03% | 448 |
|
|
2023
Q1 | $110M | Sell |
712,810
-94,499
| -12% | -$14.6M | 0.06% | 336 |
|
|
2022
Q4 | $151M | Buy |
807,309
+67,000
| +9% | +$12.5M | 0.08% | 260 |
|
|
2022
Q3 | $93M | Buy |
740,309
+447,693
| +153% | +$56.2M | 0.06% | 354 |
|
|
2022
Q2 | $46.8M | Buy |
292,616
+68,334
| +30% | +$10.9M | 0.04% | 455 |
|
|
2022
Q1 | $35.7M | Sell |
224,282
-308,463
| -58% | -$49M | 0.02% | 534 |
|
|
2021
Q4 | $112M | Buy |
532,745
+55,228
| +12% | +$11.6M | 0.07% | 299 |
|
|
2021
Q3 | $184M | Buy |
477,517
+32,977
| +7% | +$12.7M | 0.13% | 188 |
|
|
2021
Q2 | $104M | Buy |
+444,540
| New | +$104M | 0.07% | 285 |
|